Although the term work-life balance makes it seem like a dichotomous problem that can be "solved" by simply figuring out how much time you should distribute between "work" and "life," actually ...

AI assistants have arrived at a time when teachers need support to do their best work. In a national survey by the RAND ...

Bing. Another email. Bzzzz. A text message. Bloop-bloop. An incoming video call. In today’s fast-paced, always-connected world, email and text alerts arrive at all hours, deadlines creep into weekends ...

His one planning period every other day often regularly got eaten up by departmental meetings. “Unbearable is the word that ...

Ahmedabad: The Gujarat Secondary and Higher Secondary Education Board (GSHSEB) has hit a historic milestone, with the Class ...

Torque isn’t just for mechanics — it’s a key player in physics, engineering, and even everyday life. From balancing a seesaw to tightening a bolt, understanding torque helps you control stability and ...

Is work-life balance is a demand of the past? Here’s what Gen Z wants at work. Workplace trends 2026: The office cubicle may still look the same, but the mindset sitting in it has quietly ...

April 16 - OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge and scientific research capabilities, as the startup deepens its push into the ‌life ...

If that’s you, you’re not alone. This phrase fills the air in nearly every conversation I have with clients, colleagues or friends. Across higher education—amid budget cuts, hiring freezes and eroding ...

One of the world’s leading investment firms has broken its own record with the closing of its $6.3 billion Blackstone Life Sciences VI (BLXS VI) fund, which is 40% larger than its predecessor.

Blackstone Inc. closed its latest life-sciences fund with $6.3 billion of commitments, the firm’s biggest haul for backing clinical trials of medicines and technologies. The new vehicle, Blackstone ...

March 26 (Reuters) - Wave Life Sciences (WVE.O), opens new tab shares plunged 58% on Thursday after a higher dose of its experimental obesity ‌drug failed to show a clear improvement at reducing a ...